Phimmada Hatthakarnkul

Glasgow, SCT G611QH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 14, 2026

Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer.

Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer.

Journal: British journal of cancer

Published: January 29, 2026

Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 23, 2025

Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

Journal: The journal of pathology. Clinical research

Published: February 06, 2025

IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer.

IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer.

Journal: Biomolecules

Published: November 15, 2024

TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancer.

TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancer.

Journal: Translational oncology

Published: March 14, 2024

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 27, 2023

Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.

Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.

Journal: The journal of pathology. Clinical research

Published: September 15, 2023

Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.

Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.

Journal: Histology and histopathology

Published: September 08, 2023

Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor-Negative Breast Cancer.

Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor-Negative Breast Cancer.

Journal: Cancer medicine

Published: July 24, 2023

Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer.

Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer.

Journal: Journal of Cancer

Published: February 28, 2023

High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.

High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.

Journal: Cancer medicine

Published: January 30, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026